Shanghai Pioneer Holding (HKSE:01345) Total Liabilities : HK$366 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pioneer Holding Total Liabilities?

Shanghai Pioneer Holding's Total Liabilities for the quarter that ended in Dec. 2024 was HK$366 Mil.

Shanghai Pioneer Holding's quarterly Total Liabilities declined from Dec. 2023 (HK$561.26 Mil) to Jun. 2024 (HK$417.93 Mil) and declined from Jun. 2024 (HK$417.93 Mil) to Dec. 2024 (HK$365.70 Mil).

Shanghai Pioneer Holding's annual Total Liabilities declined from Dec. 2022 (HK$613.28 Mil) to Dec. 2023 (HK$561.26 Mil) and declined from Dec. 2023 (HK$561.26 Mil) to Dec. 2024 (HK$365.70 Mil).

Shanghai Pioneer Holding Total Liabilities Historical Data

The historical data trend for Shanghai Pioneer Holding's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pioneer Holding Total Liabilities Chart

Shanghai Pioneer Holding Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

612.55

511.20

613.28

561.26

365.70

Shanghai Pioneer Holding Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial															613.28	482.96	561.26	417.93	365.70

Shanghai Pioneer Holding Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shanghai Pioneer Holding's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	294.056	+	(12.239	+	59.401
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	366

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	1556.75	-	1191.054
	=	366

Shanghai Pioneer Holding's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	294.056	+	(12.239	+	59.401
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	366

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	1556.75	-	1191.054
	=	366

Shanghai Pioneer Holding Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shanghai Pioneer Holding's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pioneer Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shanghai Pioneer Holding Ltd (HKSE:01345) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.15, Lane 88 Wuwei Road, Putuo District, Shanghai, CHN, 200331

Website

http://www.pioneer-pharma.com

Shanghai Pioneer Holding Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the marketing, promotion, sales, and channel management service for imported pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, orthopedics, odontology, and wound care. The majority of its revenue derives from the Sales of pharmaceutical products. The group operates mainly in the People's Republic of China.

Executives

Ark Trust (hong Kong) Limited	2301 Trustee
Bank Of Communications Trustee Limited	2301 Trustee
Pioneer Pharma (bvi) Co.,ltd	2101 Beneficial owner
Tian Tian Limited	2201 Interest of corporation controlled by you
Li Xinzhou	2202 Interest of your spouse
Wu Qian	2201 Interest of corporation controlled by you

Shanghai Pioneer Holding Headlines

No Headlines